膝关节的干细胞治疗——非手术选择、证据与在日本就诊

膝关节疼痛，尤其是膝骨关节炎，是软骨随年龄与负荷逐渐磨损所致。当止痛药、玻尿酸注射与康复训练难以改善时，许多患者被建议接受人工关节置换手术。自体脂肪来源干细胞（ADSC）治疗作为一种不开刀的选择，正受到越来越多关注。本文由日本大阪Cell Grand Clinic的医师解说。

膝关节的干细胞治疗是什么？

采集患者自身脂肪中的间充质干细胞，经培养后注入关节腔。干细胞可通过抑制炎症、改善软骨环境、调节免疫、促进组织修复等多种机制，帮助缓解疼痛并改善关节功能。

为什么保守治疗会遇到瓶颈

非甾体抗炎药（NSAIDs）、玻尿酸与类固醇注射主要缓解症状，难以逆转已经磨损的软骨。干细胞治疗着眼于关节内部的炎症与修复环境。

证据与本院实例

2025年的多项荟萃分析提示，间充质干细胞在疼痛评分（VAS）与关节功能方面具有改善潜力。Cell Grand Clinic的一例膝骨关节炎（Kellgren–Lawrence 3级）病例已在国际期刊Cureus（2026）发表，报告显示治疗一年后疼痛VAS由8降至0、JOA评分由55升至95，MRI提示软骨与半月板改善（个案报告，效果因人而异）。

按分级看效果与细胞数量

一般而言，KL分级I–III级的改善潜力较高，IV级（重度）改善较为有限。研究还提示，单次治疗的细胞数量达到约1亿个被视为一个重要门槛。本院对细胞数量与品质进行标准化管理。

为什么选择自体细胞、选择日本

本院仅使用您自身的脂肪来源干细胞，不使用他人来源或库存细胞，从根本上降低排异与感染风险。日本对再生医疗设有严格审批制度，本院在厚生劳动省登记的再生医疗提供计划共15项。

为什么选择Cell Grand Clinic

细胞品质标准化：依ISCT标准鉴定，活性95%以上，培养代次≤P3；
由具备美国再生医学会（ABRM）专科资格、累计逾3,000例经验的若林院长全程负责；
英语直接沟通，并提供中文（微信）对接。

治疗流程与适应人群

赴日仅需两次、每次约2–3天，采集与回输分别在两次完成；约7周培养期间可在本国等待；回输后1/3/6个月随访由医师远程跟进。是否适合需结合影像与病情由医师判断。

常见问题

Q. 能替代人工关节手术吗？
它是一种非手术选择，尤其适合希望推迟或避免手术的中等程度患者；重度病例效果有限，需医师评估。

Q. 会疼吗？
注射为门诊操作，创伤小。

Q. 多久见效？
个体差异较大，通常数周至数月内逐步观察。

先修复软骨，再考虑手术

如果您希望在手术之前了解针对膝关节的再生医疗选择，欢迎联系我们，由医师为您评估。

【Author information】

Dr. Yuichi Wakabayashi, Medical Director of Cell Grand Clinic

Yuichi Wakabayashi, M.D., Ph.D.

Medical Director, Cell Grand Clinic
Diplomate, American Board of Regenerative Medicine (ABRM)

【About the Author】
Dr. Yuichi Wakabayashi is a regenerative medicine specialist with over 3,000 stem cell treatments performed. After earning his M.D. and Ph.D. at Kobe University, he conducted research at the U.S. National Institutes of Health (NIH) in the field of neurological disorders. His international achievements include first-author publication of the world's first-in-human PDE4B-specific PET tracer study, conducted in collaboration with Pfizer Inc. As Medical Director of Cell Grand Clinic, he combines evidence-based science with rigorous safety standards, dedicated to extending each patient's healthy lifespan through advanced regenerative medicine.

【Specialties】
Regenerative medicine (stem cell therapy) / Anti-aging medicine / Preventive medicine / Aesthetic regenerative medicine

【Board Certifications & Memberships】
Diplomate, American Board of Regenerative Medicine (ABRM) / Board-Certified Specialist, Japan Society of Anti-Aging Medicine / Board-Certified Specialist, Diagnostic Radiology (Japan) / Board-Certified Specialist, Nuclear Medicine (Japan) / Member, Japanese Society for Regenerative Medicine / Member, Japan Society for Dementia Research

【Education & Career】
Kobe University School of Medicine (M.D.) → Kobe University Graduate School (Ph.D.) → Kindai University School of Medicine (Lecturer) → U.S. National Institutes of Health (Research Fellow) → Cell Grand Clinic (Medical Director)

【Publications & Media】
Author: "The Simplest Guide to Regenerative Medicine" (book) / Featured in The Wall Street Journal (U.S.) / Featured on KBS Kyoto Television (Japan) / Multiple publications in international peer-reviewed journals

【Clinical Experience】
Over 3,000 stem cell treatments performed — including osteoarthritis, diabetes, chronic pain, frailty, erectile dysfunction, hair loss, and aesthetic rejuvenation

【Supervisory Statement】
The medical content of this article is supervised by the Medical Director of Cell Grand Clinic — a facility that has filed Type 2 and Type 3 Regenerative Medicine Provision Plans with Japan's Ministry of Health, Labour and Welfare (MHLW) under the Act on the Safety of Regenerative Medicine (Plan No.: PB5240089 and others), following review by an MHLW-Certified Special Committee for Regenerative Medicine. We are committed to providing accurate, evidence-based health information.

Google Scholar Profile ORCID researchmap Wikidata

ALL COLUMN